Studies available for: Attention Deficit Hyperactivity Disorder (ADHD)

See a study that interests you? Contact that study's coordinator for more information on how to participate.


Study Information:
Autism Spectrum Disorders and Symptoms of ADHD
Houston, TX
Center for Human Development Research
Children and adolescents are invited to participate in a research study that may lead to a better understanding of the nature and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in Autism Spectrum Disorders (i.e., Autistic Disorder, PDD-NOS, and Asperger's Disorder). In the first part of the study we will do psychological testing to examine the cognitive and behavioral differences in children who have Autism Spectrum Disorders and symptoms of ADHD and those who do not have symptoms of ADHD. In the second portion of the study we will examine whether a stimulant medication used for ADHD, methylphenidate (brand name: Ritalin), is effective in treating attention and behavior problems in children who have both an Autism Spectrum Disorder and symptoms of ADHD. Participants will receive a free psychological assessment and some compensation for their time in the first portion of the study.
HSC-MS-05-0239
NIH
Subject Information:
7-12 years old
Children and adolescents between the ages of 7 and 12 years old who have an Autism Spectrum Disorder (i.e., Autistic Disorder, PDD-NOS, and Asperger's Disorder) and who have IQs between 50 and 140. Previous IQ testing is not necessary to be eligible for this study. Participants may not be eligible if they have any of the following: 1. Serious sensory or motor deficits (e.g., blindness, severe cerebral palsy). 2. Serious neurological disorders (e.g., epilepsy, stroke). 3. Down syndrome, Fragile X syndrome, Tourette syndrome, or Fetal Alcohol Syndrome. 4. Bipolar Disorder or a family history of bipolar disorder in a first-degree relative. 5. Serious physical handicaps that would interfere with performance on laboratory tasks.
Study Coordinator(s) Information:
Rosleen Mansour
Rosleen.Mansour@uth.tmc.edu
713-500-2580
Principal Investigator Information:
Deborah A. Pearson, Ph.D.



Study Information:
Autism Spectrum Disorders and Symptoms of ADHD
Houston, TX
Center for Human Development Research
Children and adolescents are invited to participate in a research study that may lead to a better understanding of the nature and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in Autism Spectrum Disorders (i.e., Autistic Disorder, PDD-NOS, and Asperger's Disorder). In the first part of the study we will do psychological testing to examine the cognitive and behavioral differences in children who have Autism Spectrum Disorders and symptoms of ADHD and those who do not have symptoms of ADHD. In the second portion of the study we will examine whether a stimulant medication used for ADHD, methylphenidate (brand name: Ritalin), is effective in treating attention and behavior problems in children who have both an Autism Spectrum Disorder and symptoms of ADHD. Participants will receive a free psychological assessment and some compensation for their time in the first portion of the study.
website
HSC-MS-05-0239
NIH
Subject Information:
7-12 years old
Children and adolescents between the ages of 7 and 12 years old who have an Autism Spectrum Disorder (i.e., Autistic Disorder, PDD-NOS, and Asperger's Disorder) and who have IQs between 50 and 140. Previous IQ testing is not necessary to be eligible for this study. Participants may not be eligible if they have any of the following: 1. Serious sensory or motor deficits (e.g., blindness, severe cerebral palsy). 2. Serious neurological disorders (e.g., epilepsy, stroke). 3. Down syndrome, Fragile X syndrome, Tourette syndrome, or Fetal Alcohol Syndrome. 4. Bipolar Disorder or a family history of bipolar disorder in a first-degree relative. 5. Serious physical handicaps that would interfere with performance on laboratory tasks.
Study Coordinator(s) Information:
Rosleen Mansour
Rosleen.Mansour@uth.tmc.edu
713-500-2591
Principal Investigator Information:
Deborah A. Pearson, Ph.D.